Life Sciences
Federated Data Collaborations
Federated Data Catalogue
Data Harmonization & Integration
Drug Discovery
Disease Surveillance
Healthcare
Federal Health
Health Non-Profit
Population Genomic Initiatives
Research & Academic Organizations
Company
About Us
News
Event & Webinars
Careers
Partners
Resources
Publications
Whitepapers
Blog
Life Sciences
Federated Data Collaborations
Federated Data Catalogue
Data Harmonization & Integration
Drug Discovery
Disease Surveillance
Healthcare
Federal Health
Health Non-Profit
Population Genomic Initiatives
Research & Academic Organizations
Company
About Us
News
Event & Webinars
Careers
Partners
Resources
Publications
Whitepapers
Blog
Precision Medicine & Drug Discovery require Data.
Get the Data Now.
In the World's Largest
Federated Data Network.
100M+
Patient Data
Federated Data
Federated Software
Learning & Development
Federated Data
Global Data Network
Oncology
312 Subtypes
2,727,389
Patients
Global Data Network
Cardiometabolic
23 Subtypes
234,492
Patients
Global Data Network
Immunology & Inflammation
8 Subtypes
80,922
Patients
Global Data Network
Central Nervous System (CNS)
6 Subtypes
1,065,675
Patients
Global Data Network
Rare Disease
225 Subtypes
73,646
Patients
Global Data Network
Dermatology
1 Subtypes
40,979
Patients
Global Data Network
Endocrinology
2 Subtypes
22,852
Patients
Global Data Network
Gastrointestinal
1 Subtypes
62,456
Patients
Global Data Network
Hearing
2 Subtypes
20,571
Patients
Global Data Network
Infectious & parasitic diseases
8 Subtypes
1,331
Patients
Global Data Network
Mental Health
14 Subtypes
4,082,870
Patients
Global Data Network
Obstetrics and Gynecology
2 Subtypes
278
Patients
Global Data Network
Ophthalmic
7 Subtypes
13,043,129
Patients
Global Data Network
Respiratory
5 Subtypes
37,749
Patients
All data solutions. One Place.
Global impact.
World's Largest Federated Data Network
100million+
100m+
>200
Diseases, conditions & research areas to align to your R&D requirements
5
Continents
providing data and using the Lifebit Platform
Up to
600%
documented return on investment
Up to
65%
average time savings for users
Trusted by the world's biomedical leaders
"This platform will play an important part of Boehringer Ingelheim’s broader strategy to capture translational disease insights from large external healthcare biobanks and ultimately to accelerate the development of innovative medicines.",
"The advanced capabilities of Lifebit’s Trusted Research Environment, coupled with our focus to reimagine the infrastructure of cancer care, will enable us to unlock the potential of cancer data.",
"Through our collaboration with Lifebit, we look forward to advancing the use of research and clinical insights using clinico-genomic data for precision medicine. By doing so, we hope to accelerate the translation into clinical workflows, in a manner that will make a significant impact to improving healthcare for Singaporeans.",
"By sharing their wealth of expertise in genomics and biodata science, and empowering our scientists with the technology and skills to leap-forward our research, Lifebit demonstrated it is the industry leader providing true end-to-end solutions that embrace all community standards.",
"I am incredibly excited that Lifebit and AWS joined us to launch the next phase of our research capabilities."
"This platform will play an important part of Boehringer Ingelheim’s broader strategy to capture translational disease insights from large external healthcare biobanks and ultimately to accelerate the development of innovative medicines.",
"The advanced capabilities of Lifebit’s Trusted Research Environment, coupled with our focus to reimagine the infrastructure of cancer care, will enable us to unlock the potential of cancer data.",
"Through our collaboration with Lifebit, we look forward to advancing the use of research and clinical insights using clinico-genomic data for precision medicine. By doing so, we hope to accelerate the translation into clinical workflows, in a manner that will make a significant impact to improving healthcare for Singaporeans.",
"By sharing their wealth of expertise in genomics and biodata science, and empowering our scientists with the technology and skills to leap-forward our research, Lifebit demonstrated it is the industry leader providing true end-to-end solutions that embrace all community standards.",
"I am incredibly excited that Lifebit and AWS joined us to launch the next phase of our research capabilities."
"This platform will play an important part of Boehringer Ingelheim’s broader strategy to capture translational disease insights from large external healthcare biobanks and ultimately to accelerate the development of innovative medicines.",
"The advanced capabilities of Lifebit’s Trusted Research Environment, coupled with our focus to reimagine the infrastructure of cancer care, will enable us to unlock the potential of cancer data.",
"Through our collaboration with Lifebit, we look forward to advancing the use of research and clinical insights using clinico-genomic data for precision medicine. By doing so, we hope to accelerate the translation into clinical workflows, in a manner that will make a significant impact to improving healthcare for Singaporeans.",
"By sharing their wealth of expertise in genomics and biodata science, and empowering our scientists with the technology and skills to leap-forward our research, Lifebit demonstrated it is the industry leader providing true end-to-end solutions that embrace all community standards.",
"I am incredibly excited that Lifebit and AWS joined us to launch the next phase of our research capabilities."
From the Pioneers of Federation.
Easy to use. Easy to Love.
All data solutions.
One Place.
Single Federated Platform Experience.
All distributed data.
Just where you want it.
Thanks to federation.
The World's Most Secure Platform.
Because Biomedical Data Needs it.
End-to-End Data Governance and Security by Design
based on the most advanced federated architecture in the industry
The Latest.
Take a look at what's new, right now
March 28, 2024
Current US regulatory guidance on using real world data in research and clinical trials
Continue Reading
